OMAYRA SILVA: Open Payments
NPI 1619502218 · OAK BROOK, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,472 in 79 payments from 14 companies in 2025. Trend: 2023 $3,918 · 2024 $3,985 · 2025 $1,472
Food & beverage: $1,472
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 16 | $370 |
| ABBVIE INC. | 19 | $266 |
| Currax Pharmaceuticals LLC | 21 | $194 |
| Boston Scientific Corporation | 1 | $121 |
| Vanda Pharmaceuticals Inc. | 1 | $108 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $89 |
| AstraZeneca Pharmaceuticals LP | 4 | $81 |
| Lilly USA, LLC | 3 | $72 |
| Aimmune Therapeutics, Inc. | 4 | $57 |
| Exact Sciences Corporation | 2 | $47 |
Products named: Wegovy, CONTRAVE, VRAYLAR, APOLLO ESG System, JARDIANCE, FANAPT, Ozempic, QULIPTA.
Industry payments across IL — which companies pay providers there.
